Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Akums Pharma’s IPO to open on July 30, 2024
Price Band fixed at ₹ 646 to ₹ 679 per equity share of face value of ₹ 2 each
NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical…
According to GlobalData, NewAmsterdam’s obicetrapib is expected to be the most promising agent to launch in the dyslipidemia…
Eisai and EcoNaviSta collaborate to build a dementia ecosystem
Eisai and EcoNaviSta will conduct joint research aimed at the early detection of MCI and dementia even in healthy seniors, and…
The politics of health: how elections will impact on life sciences
Ivor Campbell, Chief Executive, Snedden Campbell, a specialist recruitment consultant for the medical technology industry…
DP World receives the AEO-LO program accreditation administered by CBIC
The certification, under the aegis of the WCO SAFE Framework of Standards, is awarded to companies whose operations strengthen…
Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
RCC diagnosed incident cases to reach 230,000 in 8MM by 2033: GlobalData
According to GlobalData epidemiologists, there were 19.90 per cent of stage III diagnosed incident cases of RCC and 17.90 per cent…
Budget 2024-25 prioritises R&D, education and business for MSMEs
Industry stakeholders appreciate the efforts made towards increasing employment, skill-building and implementation of various…
Alembic gains USFDA final approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg,…
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolixin Tablets, 1 mg, 2.5 mg, 5mg,…
Novo Nordisk’s Wegovy gets MHRA nod for use to lower heart risks
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular…
Recent study shows BioCity’s potential to differentiate in kidney disease space
The study could be of high clinical value to nephrologists who are seeking an optimal treatment of choice for IgAN patients, which…
Union Budget 2024-25 reflects a forward-looking and inclusive approach
Anil Matai, Director General, OPPI expressed that while positive strides were taken in the Union Budget 2024-25, the pharma sector…
The budget allocation for R&D will be beneficial for the clinical trial industry
Industry stakeholders share their views after the announcement of the Union Budget 2024-25. Increased allocation for R&D,…
Decoding Budget 2024-25: A lacklustre budget for pharma
The Finance Minister announced the Budget for 2024-25 on July 23, during the Monsoon Session of Parliament
Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution
According to IQVIA, the product had US sales of approximately $ 153 million for the twelve months ended December 2023
ZIM Laboratories gains approval to market Azithromycin for Oral Suspension 200 mg/5ml (40 mg/ml) in…
Azithromycin Oral Suspension is differentiated in taste-masked suspension dosage. This is the first marketing authorisation for…
Zydus receives final US FDA nod for Valsartan Tablets
Valsartan tablets had annual sales of $149.5 mn in the United States (IQVIA MAT May 2024)
SynaptixBio collaborates with Evotec to boost search for rare disease therapies
SynaptixBio and Evotec are working to develop new candidate therapies for a specific leukodystrophy
IPC waves off TABST in Indian Pharmacopoeia
The IPC’s decision to waive the TABST will reduce the number of animals subjected to unnecessary testing and underscores the…